theheart.org: Interventional Surgery news and studies. Duke and Mayo partnership.

Interventional/Surgery

Drug-Eluting Stents: Head-to-Head Clinical Trial Results

Oct 16, 2009 11:06 EDT

How do drug-eluting stents compare? Our panel of experts, Drs. Stone, Kereiakes, Serruys, and Windecker discuss the late-breaking trials at TCT 2009 of DES vs DES.

Clinical cardiology

New Data on Polyvascular Disease and ACS

1 COMMENT - Jun 23, 2009 09:40 EDT

Recently published data suggest that prior polyvascular disease increases the risk for inhospital adverse events in patients with ACS. Join Drs. Deepak Bhatt, Jean-Pierre Bassand, and José R. Gonzalez-Juanatey for a discussion of the current data on identification and management of patients with polyvascular disease.

Clinical cardiology

Combination Therapy and Cardiovascular Events: A Neurologist's Perspective

1 COMMENT - Jun 17, 2009 11:48 EDT

AF can lead to stroke, congestive heart failure, and other serious complications. Successful management should include reducing these risks. Join our expert panel, Drs. Peter Rothwell, Donald Easton, and Mark Alberts, as they discuss new data and strategies for improving outcomes in patients with AF.

Clinical cardiology

2009 Antiplatelet Debate: What's New in ACS

6 COMMENTS - Jun 12, 2009 15:03 EDT

Despite modern therapy, the rates of death, MI, bleeding, and readmission remain high in patients with ACS. Join Drs. Jeffery Popma, Héctor Bueno, Freek Verheugt, and Sunil. Rao for a review of the latest data on antiplatelet therapy for patients with ACS.

Interventional/Surgery

Variable Rate Contrast Injection in the Cath Lab

7 COMMENTS - May 11, 2009 10:00 EDT

Variable rate contrast delivery systems have the potential to improve workflow and patient outcomes by providing a more precise flow of contrast. Watch Dr. Jeffrey Moses and his team as they demonstrate the use of the device in the cath lab in a patient with complex lesions.

Acute Coronary Syndromes

ACC 2009: Emerging Insights Into Early Use of Antithrombotic Therapy in NSTEMI Patients

1 COMMENT - Apr 20, 2009 12:00 EDT

Join Dr. Newby for a discussion of new data on antithrombotic choices and management of NSTEMI patients.

Clinical cardiology

Balancing the Benefit and Risk of Antiplatelet Therapy in Clinical Practice

4 COMMENTS - Dec 4, 2008 10:08 EST

Several recent studies have demonstrated that patients with atherothrombosis who experience bleeding may be at increased risk for long-term adverse ischemic events. Whereas the specific mechanism(s) that may explain the correlation between bleeding and ischemic events remains to be fully elucidated, these findings may have important ramifications for the selection of appropriate antiplatelet therapy. Drs. Berger, Mehta, Simon, Steg, and White discuss.

Clinical cardiology

Antiplatelet Therapy in Atherothrombotic Disease

1 COMMENT - Dec 3, 2008 09:00 EST

Harmonizing guideline recommendations for antiplatelet therapy with recent clinical trial data and concerns about bleeding can pose a challenge. Drs Berger, Mehta, Simon, Steg, and White each give presentations addressing issues relating to the appropriate use of antiplatelet therapy in patients with atherothrombotic disease

Heart failure

What Happened at AHA 2008? Mayo Clinic Perspective

Nov 26, 2008 13:20 EST

In our first program Drs Gibbons, Holmes, and Simari discuss cell therapy and the latest trials in intervention. Our second program features Drs Gibbons, Ackerman, and Redfield discuss personalized genomics and heart failure.

Clinical cardiology

Antiplatelet Therapy for the Prevention of Stroke in AF

18 COMMENTS - Nov 26, 2008 09:53 EST

Warfarin remains the cornerstone of stroke prevention in patients with AF. However, many patients are unable or unwilling to take it. Could antiplatelet therapy fill this gap? How might investigational anticoagulants change the playing field? Dr Naccarelli leads a panel discussion with Drs Connolly and Camm.

	Yes
	No